Sign up to save your podcasts
Or
Share Screening Newborns' DNA -- Why Not?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Screening Newborns' DNA -- Why Not?
Marshall Summar and Jess Gilbert Thoene talk about how newborn screening has evolved and the almost unimaginable impact the Orphan Drug Act has had on product development for rare diseases since 1983.
View all episodes
By MedscapeMarshall Summar and Jess Gilbert Thoene talk about how newborn screening has evolved and the almost unimaginable impact the Orphan Drug Act has had on product development for rare diseases since 1983.